Industry news

Medtronic launches new bone cement
Medtronic, Inc., recently launched a new type of bone cement in the United States for use in the treatment of patients with vertebral compression fractures who are undergoing Kyphon balloon kyphoplasty. Kyphon ActivOs 10 Bone Cement contains hydroxyapatite, which is chemically and structurally similar to the mineral component of bone. According to the manufacturer, in an animal trial of the substance, new bone formed on the surface of the cement without an intervening fibrous tissue layer, and no inflammatory foreign body reaction was observed, suggesting that the surface of the cement is compatible with bone.

For more information, visit www.kyphon.com or www.medtronic.com

FDA clears Intego for use in bone cancer imaging
Medrad, Inc., has received clearance from the U.S. Food and Drug Administration (FDA) to market the Medrad Intego Positron Emission Tomography (PET) Infusion System for sodium fluoride (F18-NaF) administration in PET imaging. F18-NaF PET is most frequently used to find and assess bone metastases. Due to its rapid uptake in the bone and quick bone clearance, the clinical evidence indicates that F18-NaF has value as a diagnostic imaging agent in bone cancer imaging. PET technology provides high resolution images that may be quantified for detailed and comparative analysis.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!

Advertisements


Advertisement